.ANALYSIS HIGHLIGHT.06 August 2024.
A sizable randomized controlled test with cisgender females highlights the difficulties of fidelity to a daily oral preexposure prophylaxis routine and displays that twice-yearly injection of lenacapavir can easily sustain helpful HIV deterrence amounts over 6 months.